Influence of travel burden on tumor classification and survival of head and neck cancer patients.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 17 03 2021
accepted: 09 04 2021
pubmed: 21 4 2021
medline: 6 10 2021
entrez: 20 4 2021
Statut: ppublish

Résumé

Cancer patients have to overcome various barriers to obtain diagnostics and treatment at head and neck cancer centers. Travel distance to a specialized hospital may result in psychosocial and financial distress, thus interfering with diagnostics, treatment, and follow-up care. In this study, we have aimed to analyze the association of travel distance with cTNM status, UICC stage at primary diagnosis, and survival outcomes of head and neck cancer (HNC) patients. We have analyzed data of 1921 consecutive HNC patients diagnosed between 2014 and 2019 at the head and neck cancer center of the Comprehensive Cancer Center Ulm (CCCU), Germany. Postal code-based travel distance calculation in kilometers, TNM status, and UICC stage were recorded at initial diagnosis. The assembly of travel distance-related groups (short, intermediate, long-distance) has been investigated. Moreover, group-related survival and recurrence analysis have been performed. In contrast to observations from overseas, no association of travel distance and higher cTNM status or UICC stage at primary diagnosis has been observed. Furthermore, no significant differences for recurrence-free survival and overall survival by travel distance were detected. In southern Germany, travel distance to head and neck cancer centers seems to be tolerable. Travel burden is not synonymous with travel distance alone but also involves sociodemographic, monetary, and disease-specific aspects as well as accessibility to proper infrastructure of transport and health care system.

Identifiants

pubmed: 33877433
doi: 10.1007/s00405-021-06816-3
pii: 10.1007/s00405-021-06816-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4535-4543

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Douthit N, Kiv S, Dwolatzky T, Biswas S (2015) Exposing some important barriers to health care access in the rural USA. Public Health 129(6):611–620. https://doi.org/10.1016/j.puhe.2015.04.001
doi: 10.1016/j.puhe.2015.04.001 pubmed: 26025176
Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L (2015) Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist 20(12):1378–1385. https://doi.org/10.1634/theoncologist.2015-0110
doi: 10.1634/theoncologist.2015-0110 pubmed: 26512045 pmcid: 4679078
Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D et al (2012) Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer 20(1):1–22. https://doi.org/10.1007/s00520-011-1270-1
doi: 10.1007/s00520-011-1270-1 pubmed: 21956760
Xu Z, Becerra AZ, Justiniano CF, Boodry CI, Aquina CT, Swanger AA et al (2017) Is the distance worth it? patients with rectal cancer traveling to high-volume centers experience improved outcomes. Dis Colon Rectum 60(12):1250–1259. https://doi.org/10.1097/DCR.0000000000000924
doi: 10.1097/DCR.0000000000000924 pubmed: 29112560
Nipp RD, Lee H, Gorton E, Lichtenstein M, Kuchukhidze S, Park E et al (2019) Addressing the financial burden of cancer clinical trial participation: longitudinal effects of an equity intervention. Oncologist 24(8):1048–1055. https://doi.org/10.1634/theoncologist.2019-0146
doi: 10.1634/theoncologist.2019-0146 pubmed: 30988039 pmcid: 6693715
Nipp RD, Powell E, Chabner B, Moy B (2015) Recognizing the financial burden of cancer patients in clinical trials. Oncologist 20(6):572–575. https://doi.org/10.1634/theoncologist.2015-0068
doi: 10.1634/theoncologist.2015-0068 pubmed: 25986245 pmcid: 4571792
Farquhar DR, Masood MM, Lenze NR, Mcdaniel P, Mazul A, Sheth S et al. Travel time to provider is associated with advanced stage at diagnosis among low income head and neck squamous cell carcinoma patients in North Carolina. Oral Oncol 2019; 89(115–120. https://doi.org/ https://doi.org/10.1016/j.oraloncology.2018.12.029
Borno HT, Zhang L, Siegel A, Chang E, Ryan CJ (2018) At what cost to clinical trial enrollment? A retrospective study of patient travel burden in cancer clinical trials. Oncologist 23(10):1242. https://doi.org/10.1634/theoncologist.2017-0628
doi: 10.1634/theoncologist.2017-0628 pubmed: 6263122 pmcid: 6263122
Schmitz R, Adam MA, Blazer DG 3rd (2019) Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival. World J Surg Oncol 17(1):180. https://doi.org/10.1186/s12957-019-1728-z
doi: 10.1186/s12957-019-1728-z pubmed: 31684956 pmcid: 6829854
Graboyes EM, Ellis MA, Li H, Kaczmar JM, Sharma AK, Lentsch EJ et al (2018) Racial and ethnic disparities in travel for head and neck cancer treatment and the impact of travel distance on survival. Cancer 124(15):3181–3191. https://doi.org/10.1002/cncr.31571
doi: 10.1002/cncr.31571 pubmed: 29932220
Xu Z, Aquina CT, Justiniano CF, Becerra AZ, Boscoe FP, Schymura MJ et al (2020) Centralizing rectal cancer surgery: what is the impact of travel on patients? Dis Colon Rectum 63(3):319–325. https://doi.org/10.1097/DCR.0000000000001581
doi: 10.1097/DCR.0000000000001581 pubmed: 32045397
Herb J, Dunham L, Stitzenberg K (2019) Lung cancer surgical centralization disproportionally worsens travel burden for rural patients. J Am Coll Surg 229(4):S157–S158. https://doi.org/10.1016/j.jamcollsurg.2019.08.349
doi: 10.1016/j.jamcollsurg.2019.08.349
Aggarwal A, Van Der Geest SA, Lewis D, Van Der Meulen J, Varkevisser M (2020) Simulating the impact of centralization of prostate cancer surgery services on travel burden and equity in the English National Health Service: a national population based model for health service re-design. Cancer Med 9(12):4175–4184. https://doi.org/10.1002/cam4.3073
doi: 10.1002/cam4.3073 pubmed: 32329227 pmcid: 7300407
Barakat LP, Schwartz LA, Szabo MM, Hussey HM, Bunin GR (2012) Factors that contribute to post-treatment follow-up care for survivors of childhood cancer. J Cancer Surviv 6(2):155–162. https://doi.org/10.1007/s11764-011-0206-6
doi: 10.1007/s11764-011-0206-6 pubmed: 22170442
Vahl JM, Wigand MC, Denkinger M, Dallmeier D, Steiger C, Welke C et al (2021) Increasing mean age of head and neck cancer patients at a german tertiary referral center. Cancers 13(4):832. https://doi.org/10.3390/cancers13040832
doi: 10.3390/cancers13040832 pubmed: 33671152 pmcid: 7922863
Kaatsch P, Spix C, Katalinic A, Hentschel S. Krebs in Deutschland 2007/2008. 2012; http://dx.doi.org/ https://doi.org/10.25646/3161
Jain R, Menzin J, Lachance K, Mcbee P, Phatak H, Nghiem PT (2019) Travel burden associated with rare cancers: the example of Merkel cell carcinoma. Cancer Med 8(5):2580–2586. https://doi.org/10.1002/cam4.2085
doi: 10.1002/cam4.2085 pubmed: 30950224 pmcid: 6536956
Holmes JA, Carpenter WR, Wu Y, Hendrix LH, Peacock S, Massing M et al (2012) Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients. J Urol 187(3):883–888. https://doi.org/10.1016/j.juro.2011.10.156
doi: 10.1016/j.juro.2011.10.156 pubmed: 22248516
Huang B, Dignan M, Han D, Johnson O (2009) Does distance matter? Distance to mammography facilities and stage at diagnosis of breast cancer in Kentucky. J Rural Health 25(4):366–371. https://doi.org/10.1111/j.1748-0361.2009.00245.x
doi: 10.1111/j.1748-0361.2009.00245.x pubmed: 19780916
Smith AK, Shara NM, Zeymo A, Harris K, Estes R, Johnson LB et al (2015) Travel patterns of cancer surgery patients in a regionalized system. J Surg Res 199(1):97–105. https://doi.org/10.1016/j.jss.2015.04.016
doi: 10.1016/j.jss.2015.04.016 pubmed: 26076685
Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA et al. Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study. Ann Epidemiol 2017; 27(11): 731–738 e731. https://doi.org/ https://doi.org/10.1016/j.annepidem.2017.10.006
Lin CC, Bruinooge SS, Kirkwood MK, Olsen C, Jemal A, Bajorin D et al (2015) Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance. J Clin Oncol 33(28):3177. https://doi.org/10.1200/JCO.2015.61.1558
doi: 10.1200/JCO.2015.61.1558 pubmed: 26304878 pmcid: 4979096
Ahmed S, Iqbal M, Le D, Iqbal N, Pahwa P. Travel distance and use of salvage palliative chemotherapy in patients with metastatic colorectal cancer. J Gastrointest Oncol 2018; 9(2): 269–274. https://doi.org/ https://doi.org/10.21037/jgo.2017.12.01
Stephens JM, Bensink M, Bowers C, Hollenbeak CS (2019) Risks and consequences of travel burden on prophylactic granulocyte colony-stimulating factor administration and incidence of febrile neutropenia in an aged Medicare population. Curr Med Res Opin 35(2):229–240. https://doi.org/10.1080/03007995.2018.1465906
doi: 10.1080/03007995.2018.1465906 pubmed: 29661043
Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J (2000) Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer 82(11):1863–1866. https://doi.org/10.1054/bjoc.1999.1079
doi: 10.1054/bjoc.1999.1079 pubmed: 10839303 pmcid: 2363217
O’connor SC, Mogal H, Russell G, Ethun C, Fields RC, Jin L et al. The effects of travel burden on outcomes after resection of extrahepatic biliary malignancies: results from the US Extrahepatic Biliary Consortium. Journal of Gastrointestinal Surgery 2017; 21(12): 2016–2024. https://doi.org/ https://doi.org/10.1016/j.jamcollsurg.2016.06.308
Bürkert C (2019) Empirische Untersuchung I: Diskussion. In: Aktive Mobilität im ländlichen und städtischen Raum. Springer, p 133–145. https://doi.org/ https://doi.org/10.1007/978-3-658-28010-9_7
Heinrich D, Löhler J (2016) Auswirkungen aktueller Trends in Gesellschaft, Medizin und Politik auf die Zukunft der HNO-Heilkunde. HNO 64(4):213–216. https://doi.org/10.1007/s00106-016-0133-y
doi: 10.1007/s00106-016-0133-y pubmed: 26936381
Kunstmann W, Butzlaff M, Böcken J. Free choice of doctors in Germany in retrospect. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2002; 64(3): 170–175. https://doi.org/ https://doi.org/10.1055/s-2002-22318
Woolhandler S, Himmelstein DU (2020) Intersecting US epidemics: COVID-19 and lack of health insurance. In:American College of Physicians. https://doi.org/ https://doi.org/10.7326/M20-1491
Ross JS, Detsky AS (2009) Health care choices and decisions in the United States and Canada. JAMA 302(16):1803–1804. https://doi.org/10.1001/jama.2009.1566
doi: 10.1001/jama.2009.1566 pubmed: 19861673 pmcid: 2835156
Speicher PJ, Englum BR, Ganapathi AM, Wang X, Hartwig MG, D’amico TA et al. (2017) Traveling to a high-volume center is associated with improved survival for patients with esophageal cancer. Ann Surg 265(4): 743.
Dreisbach SM, Vij M, Dreisbach JL (2020) Travel Motivations of Cancer Patients. In: Global Developments in Healthcare and Medical Tourism. IGI Global, p 78–95. https://doi.org/ https://doi.org/10.4018/978-1-5225-9787-2.ch005
Macready N (2007) Developing countries court medical tourists. Lancet 369(9576):1849–1850. https://doi.org/10.1016/S0140-6736(07)60833-2
doi: 10.1016/S0140-6736(07)60833-2 pubmed: 17549816
Graboyes EM, Maurer S, Park Y, Marsh CH, Mcelligott JT, Day TA et al (2020) Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors. Psychooncology 29(12):1988–1994. https://doi.org/10.1002/pon.5399
doi: 10.1002/pon.5399 pubmed: 32350999
Van Den Brink JL, Moorman PW, De Boer MF, Hop WC, Pruyn JF, Verwoerd CD et al (2007) Impact on quality of life of a telemedicine system supporting head and neck cancer patients: a controlled trial during the postoperative period at home. J Am Med Inform Assoc 14(2):198–205. https://doi.org/10.1197/jamia.M2199
doi: 10.1197/jamia.M2199 pubmed: 17213498 pmcid: 2213461
Roberts GH, Dunscombe PB, Samant RS (2002) Geographic delivery models for radiotherapy services. Australas Radiol 46(3):290–294. https://doi.org/10.1046/j.1440-1673.2002.01062.x
doi: 10.1046/j.1440-1673.2002.01062.x pubmed: 12196239
Kelly C, Hulme C, Farragher T, Clarke G (2016) Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open 6(11):e013059. https://doi.org/10.1136/bmjopen-2016-013059
doi: 10.1136/bmjopen-2016-013059 pubmed: 27884848 pmcid: 5178808

Auteurs

J M Vahl (JM)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany. julius-malte.vahl@uniklinik-ulm.de.

A von Witzleben (A)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

C Welke (C)

Clinical Cancer Registry Comprehensive Cancer Center Ulm, Ulm University Medical Center, 89081, Ulm, Germany.

J Doescher (J)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

M N Theodoraki (MN)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

M Brand (M)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

P J Schuler (PJ)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

J Greve (J)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

T K Hoffmann (TK)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

S Laban (S)

Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH